Showing results (4981-4990 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|October 30, 2015
The role of NADPH oxidase in vascular disease--hypertension, atherosclerosis & strokeStephen P Gray, Karin A M Jandeleit-DahmCurrent Pharmaceutical Design|October 30, 2015
Cross-Talk Between TGF-β and NADPH Oxidases During Liver Fibrosis and HepatocarcinogenesisEva Crosas-Molist, Esther Bertran, Isabel FabregatCurrent Pharmaceutical Design|October 7, 2015
GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand?Djordje S Popovic, Edita Stokic, Stevan L PopovicCurrent Pharmaceutical Design|June 14, 2016
Anticancer Potential of Ginger: Mechanistic and Pharmaceutical AspectsIndu Pal Kaur, Parneet Kaur Deol, Kanthi Kiran Kondepudi, et al.Current Pharmaceutical Design|June 15, 2016
Dry Eye Disease: Present Challenges in the Management and Future TrendsZahraa Al-Saedi, Allison Zimmerman, Rinda Devi Bachu, et al.Current Pharmaceutical Design|May 7, 2016
Prognostic Significance of Asymptomatic Myocardial Ischemia in Women vs. MenKi E Park, C Richard ContiCurrent Pharmaceutical Design|June 10, 2016
Essential Oils and Pure Volatile Compounds as Potential Drugs in Alzheimer's Disease Therapy: An Updated Review of the LiteratureAntonella Maggio, Sergio Rosselli, Maurizio BrunoCurrent Pharmaceutical Design|June 10, 2016
Challenges in the Development of Antifungal Agents Against Candida: Scope of Phytochemical ResearchAijaz Ahmad, Julitha Molepo, Mrudula PatelCurrent Pharmaceutical Design|May 28, 2016
Antiphospholipid Antibody-Mediated Thrombotic Mechanisms in Antiphospholipid Syndrome: Towards Pathophysiology-Based TreatmentMd Asiful Islam, Fahmida Alam, Teguh Haryo Sasongko, et al.Current Pharmaceutical Design|September 2, 2014
Pathophysiology of idiopathic atrial fibrillation - prognostic and treatment implicationsB Weijs, U Schotten, H J G M CrijnsPageof 1,008